Article Information
History
- June 24, 2022.
Article Versions
- Version 1 (June 14, 2022 - 08:25).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- José A. Castro-Rodriguez, PhD1,
- Eleanor N. Fish, PhD2,
- Tobi Kollmann, PhD3,
- Carolina Iturriaga, RN1,
- Yuliya Karpievitch, PhD3,
- Casey Shannon, BSc4,
- , BScVirginia Chen4,
- Robert Balshaw, PhD5,
- Samuel T. Montgomery, PhD3,
- Joseph Ho, MSc3,
- Rym Ben Othman, PhD3,
- Radhouana Aniba, PhD3,
- Francisca Gidi-Yunge, DDS1,
- Lucy Hartnell, MSc3,
- Guillermo Pérez-Mateluna, Biotech1,
- Marcela Urzúa, RN1,
- Scott Tebbutt, PhD4,
- Diego García-Huidobro, PhD1,
- Cecilia Perret, MD1,
- Arturo Borzutzky, MD1 and
- Stephen M. Stick, PhD3,*
- 1Pontifical Catholic University of Chile
- 2University of Toronto
- 3Telethon Kids Institute
- 4Prevention of Organ Failure (PROOF) Centre of Excellence
- 5Centre for Healthcare Innovation, University of Manitoba
- ↵*Corresponding author: Professor Stephen Stick stephen.stick{at}health.wa.gov.au
Posted June 24, 2022.
Interferon Beta-1α ring prophylaxis to reduce household transmission of SARS-CoV-2: the Containing Coronavirus Disease-19 randomized clinical trial
